Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
ABM Industries, a leading provider of integrated facility solutions, announced it will release its fiscal Q3 2026 financial results before market open on September 8, 2026. The company will also host a conference call and webcast to discuss the results, providing insights into its performance and strategic outlook.
Nanox Imaging Ltd, a Nasdaq-listed medical imaging technology company, will release its Q2 2026 financial results before market open on September 9, 2026. The company will hold a conference call to discuss the results and provide a business update, highlighting its integrated medical imaging and AI healthcare platform.
Nasdaq released mid-month short interest positions for August 14, 2026, showing a slight decrease in total shares sold short across Nasdaq Global Market and Nasdaq Capital Market securities compared to the prior period. The average days to cover short positions also declined, indicating reduced short selling activity in the market.
Adial Pharmaceuticals has granted inducement stock options to a new employee under Nasdaq rules, coinciding with its strategic shift following the acquisition of Azora Therapeutics. The company's lead program now focuses on AT177 for ulcerative colitis, with IND filing and clinical trials planned in 2027.
Liftoff Mobile, a NASDAQ-listed company specializing in AI-driven marketing and monetization solutions for mobile apps, announced that its CEO Jeremy Bondy will present at the Goldman Sachs Communacopia + Technology Conference in September 2026. The presentation aims to showcase Liftoff's growth and technological capabilities in the app economy.
Coherent Corp. announced the unveiling of its new PhotonLink™ platform at the 2026 European Conference on Optical Communication (ECOC). The platform integrates the complete optical signal chain to enhance bandwidth, performance, and energy efficiency in next-generation datacenter architectures. The unveiling event will include presentations from ke…
Ascendis Pharma announced that it will present Week 104 data from its pivotal ApproaCH Trial of once-weekly TransCon CNP (navepegritide) at the ISDS 2026 meeting. The data show durable improvements in growth and multiple physical functioning parameters in children with achondroplasia, alongside a safety profile similar to placebo. The FDA has appro…
Spyre Therapeutics announced promising topline results from the RA sub-study of its Phase 2 SKYWAY trial evaluating SPY072. Both low and high doses of SPY072 showed statistically significant improvements versus placebo on key efficacy endpoints with a favorable safety profile. However, the magnitude of effect did not meet the company's internal thr…
Wix.com Ltd. announced that its management will participate in a fireside chat at the upcoming Citi 2026 Global Technology Conference, highlighting its continuing focus on growth and innovation following its recent acquisition of Base44. The event will be accessible via live audio webcast on Wix's investor relations site.
Atlassian just ripped higher on GAAP profitability and AI-driven product adoption even as management trimmed growth guidance. The market is rewarding margins and Rovo-driven cloud uptake; technicals show momentum but the name is overbought and still carries valuation and execution risk. This is a tactical long with a clear entry, stop and target de…
Comfort Systems USA (FIX) stands squarely in the crosshairs of the AI data-center buildout. With a backlog north of $14B, outsized cash generation and a conservative balance sheet, the company can meaningfully outgrow the broader construction cycle this year. Valuation is premium, but the risk/reward looks attractive from current levels for a long-…
Polaris (PII) is a cash-generative recreational products franchise with a 4.2% yield, a large addressable UTV/marine market tailwind and recent operational wins that should support a multi-month recovery. The stock is trading below key moving averages and at a sub-1x price-to-sales multiple. We lay out an actionable long trade with entry, stop and …
Lake City Bank, a subsidiary of Lakeland Financial Corporation, was ranked 15th among US banks with $5 billion to $50 billion in assets according to Bank Director Magazine's 2026 RankingBanking list. The ranking, based on 2025 year-end data focusing on profitability, asset quality and capital adequacy, also placed Lake City Bank first among Indiana…
Great Elm Group, Inc. plans to release its fiscal 2026 Q4 and full year financial results on August 26, 2026, followed by a conference call and webcast on August 27, 2026, to discuss the results. The company is an alternative asset manager with a focus on credit, real estate, and specialty finance sectors.
Tuya ($1.76) looks set to benefit from accelerating adoption of its AI Agent and Hey Tuya assistant, improving technical momentum, and a sub-$1.1B market cap that leaves room for a re-rating if growth steadies. This trade idea lays out an actionable entry at $1.76, a stop at $1.59, and a target of $2.40 over a mid-term 45 trading day horizon, with …
Supermicro (SMCI) has been hit hard but the core business - high-performance servers and AI-optimized systems - still sits on a favorable secular runway. With shares well off prior highs and a rebound in AI spending increasingly visible, this is a tactical long idea for disciplined traders willing to accept execution risk and near-term cyclicity.
Options activity in Kohl’s Corp. has been dominated by puts, with more than 15,000 put contracts traded and overall options volume near 19,000 contracts. Short-dated puts at strikes below the current share price saw the largest new positions, while implied volatility climbed above 70%, signaling that market participants are preparing for a sizable …
KLA is uniquely exposed to the semiconductor equipment sweet spot driving capital spending into 2027: metrology/inspection for advanced packaging and a multi-year memory/AI-capex cycle. Strong free cash flow ($3.77B), exceptional ROE (76%), and an improving revenue mix justify a long-term swing trade, even after a high P/E. Enter around $183, stop …
International Monetary Fund Managing Director Kristalina Georgieva said the global economy has so far withstood the energy shock from the Iran conflict better than expected, citing a mix of supply responses and demand changes. At the same time, she warned of mounting fiscal pressures in some countries, signaled by rising bond yields and a stalled d…
U.S. equities saw notable intraday moves on Tuesday, with semiconductor, biotech and other technology-related names among the strongest performers. Advanced Micro Devices and Moderna were standout gainers after analyst upgrades and trial-related optimism, while a set of mid- and small-cap companies posted double-digit percentage increases. Energy a…
A recently signed contract between SLB and Venezuela’s state oil company PDVSA grants the U.S. oilfield services and technology provider access to Venezuela’s oilfield datasets. The deal covers organizing, modernizing and rebuilding geological and production databases damaged by years of underinvestment and a recent ransomware attack, and includes …
<p>CoreWeave is positioned as a high-growth GPU cloud specialized for AI workloads. Recent pricing action from Nvidia that raises GPU list prices is widely seen as a headwind for cloud users and smaller GPU resellers. I argue it can be a net positive for CoreWeave: price hikes favor providers with scale, deep vendor relationships, and differentiate…
Fiserv (FISV) trades at ~10x earnings and an EV/EBITDA of ~7.2 with free cash flow near $3.93B. Recent activist involvement, a CEO transition, and possible asset monetizations (including the Clover business) create a clear path to earnings upside and multiple expansion. I favor a long trade at current levels with a $75 target over the next 180 trad…
Immatics (IMTX) is a clinical-stage TCR developer with anzu-cel (IMA203) nearing a regulatory milestone: the Phase 3 SUPRAME program is on track for a BLA submission in H1 2027. Recent Phase 1b data showed a 56% confirmed ORR and durable responses, supporting a binary catalyst that could re-rate the $1.25B market-cap equity. This trade sets a clear…
Compass Pathways (CMPS) is a high-volatility biotech with positive Phase 3 data and favorable regulatory momentum in 2026. The stock trades near $14.86 with a market cap around $2.0B. This trade idea outlines a mid-term swing long (45 trading days) with an entry at $14.86, stop at $11.50, and a target of $20.00 while mapping the clinical, regulator…
